Without question, advanced cellular and gene therapies require well-defined cold-chain management solutions that reduce risk and include all elements of packaging, data collection and logistics expertise to ensure high-quality, effective treatments reach the point of care, and ultimately, the patient.
Evaluating the use of new tumor measurement tools for studies of molecular-targeted cancer therapies.
Why the requirement for the collection of cardiac safety data?
PFT Global is the renamed clinical trials division of nSpire Health, which iCardiac acquired in July 2015.
The software allows pathology labs, hospitals, genomic cores and physicians to match patients’ test results to personalized cancer treatments, including clinical trials and experimental drugs.
The CLIA-accredited laboratory will support both research-use-only and clinical diagnostic tests.